Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.86 EUR | -1.06% | +0.43% | -10.05% |
Apr. 26 | BRENNTAG : Barclays keeps a Sell rating | ZD |
Apr. 23 | Baader lowers Brenntag to 'Add' and target to 85 euros | DP |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.74 for the current period. Therefore, the company is undervalued.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.05% | 11.7B | B | ||
-0.19% | 80.96B | B | ||
+0.09% | 48.75B | A- | ||
-4.19% | 30.73B | C | ||
+9.85% | 17.82B | B | ||
-8.09% | 9.65B | - | ||
+2.79% | 9.52B | A- | ||
+6.35% | 9.39B | C- | ||
+3.85% | 8.2B | B | ||
-8.37% | 6.03B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BNR Stock
- Ratings Brenntag SE